How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2026 · first_quarter · 1A
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Oral Health Products Inclusion Act
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
H.R. 1219, Oral Health Products Inclusion Act (whole bill)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHILIPS HOLDING USA INC. · Firm: PHILIPS HOLDING USA, INC.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2026 · second_quarter · Q2
H.R. 1219, Oral Health Products Inclusion Act (whole bill)
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2026 · first_quarter · 1A
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2026 · first_quarter · Q1
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2025 · fourth_quarter · Q4
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2025 · third_quarter · Q3
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
PHILIPS HOLDING USA INC. via PHILIPS HOLDING USA, INC.
2025 · second_quarter · Q2
Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.
Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.
Filing targets: Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)